Patients with type 1 diabetes exhibit altered cerebral metabolism during hypoglycemia

Journal of Clinical Investigation

Volumn 123, Issue 2, 2013, Pages 623-629

  Van De Ven, Kim C C ^a   Tack, Cees J ^a   Heerschap, Arend ^a   Van Der Graaf, Marinette ^a   De Galan, Bastiaan E ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON 13; GLUCOSE; HEMOGLOBIN A1C; LACTIC ACID;

ADULT; ARTICLE; BRAIN METABOLISM; CITRIC ACID CYCLE; CLINICAL ARTICLE; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLYCEMIC CONTROL; HUMAN; HYPOGLYCEMIA; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LACTATE BLOOD LEVEL; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL;

ADULT; BLOOD GLUCOSE; BRAIN; CARBON ISOTOPES; CITRIC ACID CYCLE; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUTAMIC ACID; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, BIOLOGICAL; YOUNG ADULT;

EID: 84873376882     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI62742     Document Type: Article

References (46)

1. Strachan MWJ. Frequency, causes and risk factors for hypoglycaemia in type 1 diabetes. In: Frier BM, Fisher M, eds. Hypoglycemia In Clinical Diabetes. 2nd ed. New York, New York, USA: John Wiley and Sons; 1999:49-82.
2. Biessels GJ, Staekenborg S, Brunner E, Brayne C, Scheltens P. Risk of dementia in diabetes mellitus: a systematic review. Lancet Neurol. 2006;5(1):64-74.
3. Sims-Robinson C, Kim B, Rosko A, Feldman EL. How does diabetes accelerate Alzheimer disease pathology? Nat Rev Neurol. 2010;6(10):551-559.
4. Frier BM. Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited. Diabetologia. 2011;54(2):233-236.
5. Van De Ven KC, et al. Effect of acute hypoglycemia on human cerebral glucose metabolism measured by 13C magnetic resonance spectroscopy. Diabetes. 2011;60(5):1467-1473.
6. Boumezbeur F, et al. The contribution of blood lactate to brain energy metabolism in humans measured by dynamic 13C nuclear magnetic resonance spectroscopy. J Neurosci. 2010;30(42):13983-13991.
7. Maran A, Cranston I, Lomas J, Macdonald I, Amiel SA. Protection by lactate of cerebral function during hypoglycaemia. Lancet. 1994;343(8888):16-20.
8. Smith D, Pernet A, Hallett WA, Bingham E, Marsden PK, Amiel SA. Lactate: a preferred fuel for human brain metabolism in vivo. J Cereb Blood Flow Metab. 2003;23(6):658-664.
9. Herzog RI, Sherwin RS, Rothman DL. Insulin-induced hypoglycemia and its effect on the brain: unraveling metabolism by in vivo nuclear magnetic resonance. Diabetes. 2011;60(7):1856-1858.
10. Van De Ven KC, Van der Graaf M, Tack CJ, Klomp DW, Heerschap A, De Galan BE. Optimized [1-(13) C]glucose infusion protocol for 13C magnetic resonance spectroscopy at 3T of human brain glucose metabolism under euglycemic and hypoglycemic conditions. J Neurosci Methods. 2010;186(1):68-71.
11. Henry PG, Criego AB, Kumar A, Seaquist ER. Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using (13) C nuclear magnetic resonance spectroscopy. Metabolism. 2010;59(1):100-106.
12. Fanelli CG, et al. Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetes. Diabetes. 1998;47(9):1444-1450.
13. Seaquist ER. The final frontier: how does diabetes affect the brain? Diabetes. 2010;59(1):4-5.
14. Musen G, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes. 2006;55(2):326-333.
15. Brands AM, et al. Cognitive performance, psychological well-being, and brain magnetic resonance imaging in older patients with type 1 diabetes. Diabetes. 2006;55(6):1800-1806.
16. Hershey T, Perantie DC, Warren SL, Zimmerman EC, Sadler M, White NH. Frequency and timing of severe hypoglycemia affects spatial memory in children with type 1 diabetes. Diabetes Care. 2005;28(10):2372-2377.
17. Heikkila O, Makimattila S, Timonen M, Groop PH, Heikkinen S, Lundbom N. Cerebellar glucose during fasting and acute hyperglycemia in nondiabetic men and in men with type 1 diabetes. Cerebellum. 2010;9(3):336-344.
18. Kreis R, Ross BD. Cerebral metabolic disturbances in patients with subacute and chronic diabetes mellitus: detection with proton MR spectroscopy. Radiology. 1992;184(1):123-130.
19. Oz G, et al. Human brain glycogen metabolism during and after hypoglycemia. Diabetes. 2009;58(9):1978-1985.
20. Herzog RI, Chan O, Yu S, Dziura J, McNay EC, Sherwin RS. Effect of acute and recurrent hypoglycemia on changes in brain glycogen concentration. Endocrinology. 2008;149(4):1499-1504.
21. Wyss MT, Jolivet R, Buck A, Magistretti PJ, Weber B. In vivo evidence for lactate as a neuronal energy source. J Neurosci. 2011;31(20):7477-7485.
22. Veneman T, Mitrakou A, Mokan M, Cryer P, Gerich J. Effect of hyperketonemia and hyperlacticacidemia on symptoms, cognitive dysfunction, and counterregulatory hormone responses during hypoglycemia in normal humans. Diabetes. 1994;43(11):1311-1317.
23. McCall AL, Fixman LB, Fleming N, Tornheim K, Chick W, Ruderman NB. Chronic hypoglycemia increases brain glucose transport. Am J Physiol. 1986;251(4 pt 1):E442-E447.
24. Simpson IA, et al. Blood-brain barrier glucose transporter: effects of hypo-and hyperglycemia revisited. J Neurochem. 1999;72(1):238-247.
25. Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER. Brain glucose concentrations in healthy humans subjected to recurrent hypoglycemia. J Neurosci Res. 2005;82(4):525-530.
26. Segel SA, et al. Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes. 2001;50(8):1911-1917.
27. Bingham EM, et al. Differential changes in brain glucose metabolism during hypoglycaemia accompany loss of hypoglycaemia awareness in men with type 1 diabetes mellitus. An [11C]-3-O-methyl-D-glucose PET study. Diabetologia. 2005;48(10):2080-2089.
28. Öz G, Tesfaye N, Kumar A, Deelchand DK, Eberly LE, Seaquist ER. Brain glycogen content and metabolism in subjects with type 1 diabetes and hypoglycemia unawareness. J Cereb Blood Flow Metab. 2012;32(2):256-263.
29. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI. Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes. 2006;55(4):929-934.
30. Van De Ven KC, Van der Graaf M, Tack CJ, Heerschap A, De Galan BE. Steady-state brain glucose concentrations during hypoglycemia in healthy humans and patients with type 1 diabetes. Diabetes. 2012;61(8):1974-1977.
31. Jiang L, et al. Recurrent antecedent hypoglycemia alters neuronal oxidative metabolism in vivo. Diabetes. 2009;58(6):1266-1274.
32. Puente EC, et al. Recurrent moderate hypoglycemia ameliorates brain damage and cognitive dysfunction induced by severe hypoglycemia. Diabetes. 2010;59(4):1055-1062.
33. Gruden G, Barutta F, Cavallo Perin P, Bruno G. Severe hypoglycemia and cardiovascular disease incidence in type 1 Diabetes: The EURODIAB Prospective Complications Study. Diabetes Care. 2012;35(12):e89.
34. Bolo NR, et al. Brain activation during working memory is altered in patients with type 1 diabetes during hypoglycemia. Diabetes. 2011;60(12):3256-3264.
35. Clarke WL, Cox DJ, Gonder-Frederick LA, Julian D, Schlundt D, Polonsky W. Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms. Diabetes Care. 1995;18(4):517-522.
36. De Galan BE, De Mol P, Wennekes L, Schouwenberg BJ, Smits P. Preserved sensitivity to beta2-adrenergic receptor agonists in patients with type 1 diabetes mellitus and hypoglycemia unawareness. J Clin Endocrinol Metab. 2006;91(8):2878-2881.
37. Serlie MJ, et al. Glycogen synthesis in human gastrocnemius muscle is not representative of whole-body muscle glycogen synthesis. Diabetes. 2005;54(5):1277-1282.
38. Van Den Bergh AJ, Tack CJ, Van Den Boogert HJ, Vervoort G, Smits P, Heerschap A. Assessment of human muscle glycogen synthesis and total glucose content by in vivo 13C MRS. Eur J Clin Invest. 2000;30(2):122-128.
39. Klomp DW, Renema WK, Van der Graaf M, De Galan BE, Kentgens AP, Heerschap A. Sensitivity-enhanced 13C MR spectroscopy of the human brain at 3 Tesla. Magn Reson Med. 2006;55(2):271-278.
40. Klomp DW, Kentgens AP, Heerschap A. Polarization transfer for sensitivity-enhanced MRS using a single radio frequency transmit channel. NMR Biomed. 2008;21(5):444-452.
41. Shaka AJ, Keeler J, Frenkiel T, Freeman R. An improved sequence for broadband decoupling: WALTZ-16. J Magn Reson. 1983;52:335-338.
42. Vanhamme L, Van Den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson. 1997;129(1):35-43.
43. Naressi A, et al. Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001;12(2-3):141-152.
44. Ross B, Lin A, Harris K, Bhattacharya P, Schweinsburg B. Clinical experience with 13C MRS in vivo. NMR Biomed. 2003;16(6-7):358-369.
45. Henry PG, et al. In vivo 13C NMR spectroscopy and metabolic modeling in the brain: a practical perspective. Magn Reson Imaging. 2006;24(4):527-539.
46. Henry PG, Lebon V, Vaufrey F, Brouillet E, Hantraye P, Bloch G. Decreased TCA cycle rate in the rat brain after acute 3-NP treatment measured by in vivo 1H-[13C] NMR spectroscopy. J Neurochem. 2002;82(4):857-866.